These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6321336)

  • 21. Differentiation of type 1 and type 2 herpes simplex virus by in vitro stimulation of immune lymphocytes.
    Rosenberg GL; Wohlenberg C; Nahmias AJ; Notkins AL
    J Immunol; 1972 Aug; 109(2):413-4. PubMed ID: 4340084
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay.
    Clouse KA; Bach FH; Orosz CG
    J Immunol; 1984 Jun; 132(6):2961-7. PubMed ID: 6327812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The characteristics of thymus involvement in regional and generalized forms of herpetic infection].
    Kolomiets AG; Duboĭskaia GP; Gasich EL; Kolomiets ND; Votiakov VI
    Biull Eksp Biol Med; 1993 Jun; 115(6):649-52. PubMed ID: 8397019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
    Russell AS; Kaiser J; Lao VS
    J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of indomethacin on the in vitro lymphocyte transformation response to herpes simplex virus antigen and phytohemagglutinin after marrow transplant.
    Meyers JD; Wade JC; Day LM
    J Infect Dis; 1982 Aug; 146(2):289. PubMed ID: 6286791
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte transformation test responses to cytomegalovirus in healthy adults from Britain and Iraq.
    Booth JC; Rashid SA; Aziz TA
    J Med Virol; 1987 Nov; 23(3):265-72. PubMed ID: 2828523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blast transformation reaction in ophthalmic herpes].
    Mal'khanov VB
    Oftalmol Zh; 1980; 35(4):221-4. PubMed ID: 6250110
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunity to latent viral infection: many skirmishes but few fatalities.
    Khanna KM; Lepisto AJ; Hendricks RL
    Trends Immunol; 2004 May; 25(5):230-4. PubMed ID: 15099562
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of herpes simplex virus type-1 latency in corneas.
    Xie LX; Dong XG; Kaufman HE
    Chin Med J (Engl); 1993 Apr; 106(4):288-91. PubMed ID: 8391970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on rabbit lymphocytes in vitro. XI. Superaddition of anti-allotypic lymphocyte transformation: evidence for multipotent lymphoid cells.
    Sell S; Lowe JA; Gell PG
    J Immunol; 1970 Jan; 104(1):103-13. PubMed ID: 5411500
    [No Abstract]   [Full Text] [Related]  

  • 32. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitivity of herpes simplex virus to murine gamma interferon].
    Shibayama Y; Kobayashi S
    Nippon Ganka Gakkai Zasshi; 1983; 87(10):958-62. PubMed ID: 6324563
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV.
    Brudek T; Lühdorf P; Christensen T; Hansen HJ; Møller-Larsen A
    J Neuroimmunol; 2007 Jul; 187(1-2):147-55. PubMed ID: 17493688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.
    Czarnetzki BM; Macher E
    Arch Dermatol Res; 1980; 268(3):247-55. PubMed ID: 7212769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antigenic and genomic characterization of Herpes simplex virus isolated from double genital infections].
    Martínez MJ; Saavedra T; Ojeda JM; Suárez M
    Rev Med Chil; 1996 Feb; 124(2):153-9. PubMed ID: 9213883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-immunoglobulin stimulation of murine lymphocytes. VII. Identification of an age-dependent change in accessory cell function.
    Scribner DJ; Moorhead JW
    J Immunol; 1982 Mar; 128(3):1377-81. PubMed ID: 6976991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus in human genital cancer.
    zur Hausen H
    Int Rev Exp Pathol; 1983; 25():307-26. PubMed ID: 6321379
    [No Abstract]   [Full Text] [Related]  

  • 40. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
    Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
    Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.